Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,834 companies covered, latest filing Oct 22.

  • $1.5B bought by 364 insiders at 225 companies
  • $3.5B sold by 283 insiders outside a trading plan
  • $6B sold by 839 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past month, each insider's filings added up.

  1. LENLennar
    Berkshire Hathaway Inc.10% owner, +1 joint filer
    4,758,747 shares at $80.46 Sep 23–Oct 2, 3 filings 3 superinvestors bought in Q2
    $383M
  2. CRBGCorebridge Financial
    Life Insurance Co Nippon10% owner
    6,727,632 shares at $34.19 Sep 18–Oct 20, 22 filings +5.4% to stake 2 superinvestors bought in Q2
    $230M
  3. KODKodiak Sciences
    Baker Bros. Advisors LPDirector, +5 joint filers
    1,941,755 shares at $80.85 Sep 28–29, 3 filings +11% to stake 1 superinvestor sold in Q2
    $157M
  4. SAFXXCF Global
    EEME Energy SPV I, LLC10% owner
    119M shares at $1.19 Oct 16 +109% to stake
    $142M
  5. GPIGroup 1 Automotive
    Conifer Management, L.L.C.10% owner
    400,000 shares at $244.51 Sep 24–30, 2 filings +26% to stake 2 superinvestors bought in Q2
    $97.8M
  6. UUUUniversal Safety Products
    Milton C Ault IIIDirector
    33,534 shares at $2,758.13 Sep 18–30, 3 filings
    $92.5M
  7. GMEGameStop
    Ryan CohenCEO
    1,994,130 shares at $25.29 Sep 29–Oct 13, 3 filings +4.9% to stake
    $50.4M
  8. BORRBorr Drilling
    Tor Olav TroimDirector
    9,500,000 shares at $4.53 Oct 5–15, 7 filings +31% to stake
    $43M
  9. PAMPampa Energia
    Marcos Marcelo MindlinDirector
    435,000 shares at $80.78 Oct 15 +6.4% to stake
    $35.1M
  10. GGRGogoro
    Chung-Yao YinDirector
    14.2M shares at $2.48 Oct 7 New stake
    $35.1M

Biggest sales

Past month, each insider's filings added up. Planned sales are marked.

  1. IHTInnSuites Hospitality Trust
    James F WirthCEO
    43,111 shares at $50,410.80 Oct 7 0.5% of stake Planned sale (10b5-1)
    $2.2B
  2. MDLNMedline
    GIC Private Ltd10% owner, +2 joint filers
    28.5M shares at $34.97 Oct 2–8, 2 filings
    $996M
  3. ESTCElastic
    Steven SchuurmanDirector
    3,500,000 shares at $92.43 Oct 5–12, 2 filings 58% of stake
    $323M
  4. NVDANvidia
    Mark A StevensDirector
    1,366,000 shares at $219.73 Sep 18 59% of stake
    $300M
  5. TALOTalos Energy
    Empresarial De Capitales S.a. De C.v. Control10% owner
    14.6M shares at $17.33 Oct 6–19, 5 filings 37% of stake
    $253M
  6. AVGOBroadcom
    Henry SamueliDirector
    702,190 shares at $356.04 Sep 23 1.9% of stake Planned sale (10b5-1)
    $250M
  7. THTarget Hospitality
    TDR Capital II Investments LP10% owner, +9 joint filers
    11M shares at $18.40 Oct 1 40% of stake
    $202M
  8. SNOWSnowflake
    Frank SlootmanDirector
    600,000 shares at $325.46 Sep 18–Oct 19, 2 filings 97% of stake Planned sale (10b5-1)
    $195M
  9. ANETArista Networks
    Jayshree UllalCEO
    778,531 shares at $213.68 Sep 25–Oct 9, 4 filings 4.8% of stake Planned sale (10b5-1)
    $166M
  10. KNTKKinetik
    ISQ Global Fund II GP LLC10% owner, +4 joint filers
    2,448,272 shares at $54.63 Sep 22–Oct 13, 4 filings 100% of stake
    $134M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days, most buyers first

  1. TSMTaiwan Semiconductor 19 insiders, $80K

    Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more

    Latest buy Oct 7 19 executives 20 superinvestors sold in Q2
  2. SPGSimon Property Group 11 insiders, $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  3. FULH. B. Fuller 9 insiders, $1.1M

    R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more

    Latest buy Oct 16 1 executive 1 superinvestor bought in Q2
  4. RAPPRapport Therapeutics 5 insiders, $1.6M

    Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +1 more

    Latest buy Oct 22 1 executive
  5. ATCHAtlasClear 5 insiders, $163K

    Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

    Latest buy Sep 25 3 executives
  6. RGCORGC Resources 5 insiders, $85K

    John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

    Latest buy Oct 1 3 executives
  7. WVVIWillamette Valley Vineyards 5 insiders, $81K

    Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, Chris Riccardi Director, +1 more

    Latest buy Oct 12 3 executives
  8. MPBMid Penn Bancorp 5 insiders, $25K

    Matthew G De Soto Director, Albert J. Evans Director, Joel L. Frank Director, Theodore W Mowery Director, +1 more

    Latest buy Sep 30
  9. DXDynex Capital 4 insiders, $245K

    Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO

    Latest buy Oct 20 4 executives
  10. ANIXAnixa Biosciences 4 insiders, $203K

    Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director

    Latest buy Oct 22 2 executives

ALAB insider trades

Every open-market buy and sale in ALAB, one row per filing, newest first

ALAB page
All Buys Sales
Everyone CEOs CFOs Executives Directors 10% owners
Any size $100K+ $1M+ $10M+
Hide planned sales
  1. Stefan A Dyckerhoff Director
    ALABAstera Labs
    Planned sale
    $4.7M 12,499 shares at $376.06
    Traded Oct 7 Filed Oct 9
    ↗
  2. Stefan A Dyckerhoff Director
    ALABAstera Labs
    Planned sale
    $3.4M 12,499 shares at $274.96
    Traded Sep 2 Filed Sep 3
    ↗
  3. Manuel Alba Director
    ALABAstera Labs
    Planned sale
    $51.3M 183,000 shares at $280.13 42% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  4. Stefan A Dyckerhoff Director
    ALABAstera Labs
    Planned sale
    $3.9M 12,499 shares at $311.83
    Traded Aug 6 Filed Aug 10
    ↗
  5. Manuel Alba Director
    ALABAstera Labs
    Planned sale
    $3.9M 8,491 shares at $458.38 2.9% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  6. Manuel Alba Director
    ALABAstera Labs
    Planned sale
    $16.8M 37,535 shares at $447.39 11% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  7. Manuel Alba Director
    ALABAstera Labs
    Planned sale
    $60.5M 136,974 shares at $442.01 9.6% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  8. Stefan A Dyckerhoff Director
    ALABAstera Labs
    Planned sale
    $5.6M 12,499 shares at $450.00
    Traded Jul 1 Filed Jul 2
    ↗
  9. Bethany Mayer Director
    ALABAstera Labs
    Planned sale
    $271K 686 shares at $395.04 11% of stake
    Traded Jun 24 Filed Jun 26
    ↗
  10. Jack R Lazar Director
    ALABAstera Labs
    Planned sale
    $3.6M 10,000 shares at $355.17 12% of stake
    Traded Jun 4 Filed Jun 8
    ↗
  11. Stefan A Dyckerhoff Director
    ALABAstera Labs
    Planned sale
    $4.6M 12,499 shares at $364.35
    Traded Jun 3 Filed Jun 5
    ↗
  12. Sanjay Gajendra COO
    ALABAstera Labs
    Planned sale
    $116M 400,000 shares at $290.30 7.3% of stake
    Traded May 21 Filed May 26
    ↗
  13. Philip Mazzara General Counsel and Secretary
    ALABAstera Labs
    Sale
    $232K 796 shares at $291.03 0.8% of stake
    Traded May 21 Filed May 26
    ↗
  14. Sanjay Gajendra COO
    ALABAstera Labs
    Planned sale
    $69.8M 280,000 shares at $249.19 31% of stake
    Traded May 19 Filed May 21
    ↗
  15. Philip Mazzara General Counsel and Secretary
    ALABAstera Labs
    Sale
    $2.2M 9,204 shares at $235.36 7.8% of stake
    Traded May 18 Filed May 20
    ↗
  16. Jitendra Mohan CEO
    ALABAstera Labs
    Planned sale
    $31.3M 139,951 shares at $223.61 3.6% of stake
    Traded May 18–19 Filed May 20
    ↗
  17. Sanjay Gajendra COO
    ALABAstera Labs
    Planned sale
    $9.8M 49,361 shares at $199.21 7% of stake
    Traded May 7 Filed May 11
    ↗
  18. Sanjay Gajendra COO
    ALABAstera Labs
    Planned sale
    $45.7M 230,639 shares at $198.22 26% of stake
    Traded May 7 Filed May 11
    ↗
  19. Jitendra Mohan CEO
    ALABAstera Labs
    Planned sale
    $28M 139,951 shares at $200.16 3.4% of stake
    Traded May 7 Filed May 11
    ↗
  20. Stefan A Dyckerhoff Director
    ALABAstera Labs
    Planned sale
    $2.5M 12,499 shares at $200.03
    Traded May 7 Filed May 11
    ↗
  21. Jitendra Mohan CEO
    ALABAstera Labs
    Planned sale
    $57.9M 335,881 shares at $172.24 7.6% of stake
    Traded Apr 17–20 Filed Apr 21
    ↗
  22. Stefan A Dyckerhoff Director
    ALABAstera Labs
    Planned sale
    $4.4M 24,998 shares at $175.06
    Traded Apr 17–20 Filed Apr 21
    ↗
  23. Jitendra Mohan CEO
    ALABAstera Labs
    Planned sale
    $518K 2,967 shares at $174.60 0.1% of stake
    Traded Apr 15 Filed Apr 16
    ↗
  24. Jitendra Mohan CEO
    ALABAstera Labs
    Planned sale
    $18.5M 123,750 shares at $149.68 2.7% of stake
    Traded Apr 10 Filed Apr 14
    ↗
  25. Manuel Alba Director
    ALABAstera Labs
    Planned sale
    $19.7M 183,000 shares at $107.61 36% of stake
    Traded Apr 1 Filed Apr 3
    ↗
  26. Philip Mazzara General Counsel and Secretary
    ALABAstera Labs
    Planned sale
    $1.1M 10,000 shares at $107.77 7.8% of stake
    Traded Apr 1 Filed Apr 3
    ↗
  27. Jitendra Mohan CEO
    ALABAstera Labs
    Planned sale
    $20.7M 157,500 shares at $131.58 3.4% of stake
    Traded Mar 17 Filed Mar 19
    ↗
  28. Jack R Lazar Director
    ALABAstera Labs
    Planned sale
    $325K 2,500 shares at $130.00 2.9% of stake
    Traded Mar 16 Filed Mar 17
    ↗
  29. Jack R Lazar Director
    ALABAstera Labs
    Planned sale
    $898K 7,500 shares at $119.80 7.9% of stake
    Traded Mar 5 Filed Mar 9
    ↗
  30. Philip Mazzara General Counsel and Secretary
    ALABAstera Labs
    Planned sale
    $1.2M 10,000 shares at $117.47 7.2% of stake
    Traded Mar 2 Filed Mar 4
    ↗
  31. Philip Mazzara General Counsel and Secretary
    ALABAstera Labs
    Planned sale
    $1.8M 10,000 shares at $178.41 6.8% of stake
    Traded Jan 2 Filed Jan 6
    ↗
  32. Manuel Alba Director
    ALABAstera Labs
    Planned sale
    $5.5M 33,000 shares at $166.18 8.6% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗
  33. Manuel Alba Director
    ALABAstera Labs
    Planned sale
    $24.9M 150,000 shares at $166.18 8.7% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗
  34. Jack R Lazar Director
    ALABAstera Labs
    Planned sale
    $374K 2,500 shares at $149.55 2.6% of stake
    Traded Nov 20, 2025 Filed Nov 21, 2025
    ↗

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,834 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.